FDA
approval
· 2022-01-26
FDA Approved: NEBIVOLOL — Supplemental Application (AvKARE)
Summary
FDA approved a supplemental application for Nebivolol Hydrochloride by AvKARE, indicating an additional approval related to the generic product under ANDA.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)